a decreasing trendp < 0.001
Raloxifene prescribing prior to NICE guidelines was much lower than that of tamoxifen and shows a decreasing trend both in GM (−0.396 ADQs per 1000 population per month) and nationally (−0.286, p < 0.001) (Fig. 5 ).
Raloxifene prescribing prior to NICE guidelines was much lower than that of tamoxifen and shows a decreasing trend both in GM (−0.396 ADQs per 1000 population per month) and nationally (−0.286, p < 0.001) (Fig. 5 ).